RLYB

Rallybio Corp

Latest Form 4:Purchase$84KbyADAR1 Capital Management, LLC (10% Owner) · filed May 21, 2026

Rallybio Corp (RLYB) has 6 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 10, 2026.

The most active filer is 10% Owner ADAR1 Capital Management, LLC with 8 filings. Insiders have net bought $4.2M over the trailing 6 months. The largest single insider purchase in this window was $1.7M by 10% Owner ADAR1 Capital Management, LLC on May 4, 2026.

  • Industry:Biotechnology
  • CEO:Stephen Uden
  • Employees:9
  • HQ:New Haven, CT, US
  • IPO:2021-07-29

Insider Buying

$4.2M

reported purchases (SEC code P)

Insider Selling

$4K

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$89.3M

latest known value

Source
Purchase$84KMay 21SEC ↗
Purchase$143KMay 21SEC ↗
Purchase$1.1MMay 16SEC ↗
Purchase$4KMay 16SEC ↗
Purchase$700KMay 14SEC ↗
Purchase$11KMay 14SEC ↗
Purchase$1.7MMay 7SEC ↗
Purchase$491KMay 7SEC ↗
Lieber Jonathan IFirst filing
Sale$4KFeb 23SEC ↗

Related companies

Rallybio Corp is in the Healthcare sector.